| Patent | Date |
|---|
Energetic cancer stem cells (e-CSCs): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy
Grant 11,441,195 - Lisanti , et al. September 13, 2 | 2022-09-13 |
Carbocyanine Compounds For Targeting Mitochondria And Eradicating Cancer Stem Cells
App 20220249438 - LISANTI; Michael P. ; et al. | 2022-08-11 |
Alkyl-tpp Compounds For Mitochondria Targeting And Anti-cancer Treatments
App 20220211728 - LISANTI; Michael P. ; et al. | 2022-07-07 |
Therapeutics And Methods For Predicting And Overcoming Endocrine Resistance In Breast Cancer
App 20220202836 - LISANTI; Michael P. ; et al. | 2022-06-30 |
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast
Grant 11,364,210 - Lisanti , et al. June 21, 2 | 2022-06-21 |
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
Grant 11,311,501 - Lisanti , et al. April 26, 2 | 2022-04-26 |
Vitamin C And Doxycycline: A Synthetic Lethal Combination Therapy For Eradicating Cancer Stem Cells (cscs)
App 20220117981 - Lisanti; Michael P. ; et al. | 2022-04-21 |
Targeting Hypoxic Cancer Stem Cells (cscs) With Doxycycline: Implications For Improving Anti-angiogenic Therapy
App 20220096502 - LISANTI; Michael P. ; et al. | 2022-03-31 |
Antimitoscins: Targeted Inhibitors Of Mitochondrial Biogenesis For Eradicating Cancer Stem Cells
App 20220072020 - LISANTI; Michael P. ; et al. | 2022-03-10 |
Triple Combination Therapies For Targeting Mitochondria And Killing Cancer Stem Cells
App 20220040316 - LISANTI; Michael P. ; et al. | 2022-02-10 |
Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy
Grant 11,229,657 - Lisanti , et al. January 25, 2 | 2022-01-25 |
Triple Combination Therapies For Anti-aging
App 20220016151 - LISANTI; Michael P. ; et al. | 2022-01-20 |
Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
Grant 11,197,872 - Lisanti , et al. December 14, 2 | 2021-12-14 |
Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
Grant 11,160,821 - Lisanti , et al. November 2, 2 | 2021-11-02 |
Azithromycin And Roxithromycin Derivtives As Senolytic Drugs
App 20210275560 - SOTGIA; Federica ; et al. | 2021-09-09 |
Energetic Cancer Stem Cells (e-cscs): A New Hyper-metabolic And Proliferative Tumor Cell Phenotype, Driven By Mitochondrial Energy
App 20210254177 - LISANTI; Michael P. ; et al. | 2021-08-19 |
Triphenylphosphonium-derivative Compounds For Eradicating Cancer Stem Cells
App 20210228600 - LISANTI; Michael P. ; et al. | 2021-07-29 |
Biomarkers And Therapeutics For Endocrine Therapy Resistance
App 20210215702 - LISANTI; Michael P. ; et al. | 2021-07-15 |
Mitoriboscins: Mitochondrial-based Therapeutics Targeting Cancer Cells, Bacteria And Pathogenic Yeast
App 20210186898 - Lisanti; Michael P. ; et al. | 2021-06-24 |
Targeting Mitochondrial Fission Through Mdivi-1 Derivatives
App 20210137925 - LISANTI; Michael P. ; et al. | 2021-05-13 |
Mitoriboscins: Mitochondrial-based Therapeutics Targeting Cancer Cells, Bacteria, And Pathogenic Yeast
App 20210130370 - LISANTI; Michael P. ; et al. | 2021-05-06 |
Triphenylphosphonium-derivative compounds for eradicating cancer stem cells
Grant 10,980,821 - Lisanti , et al. April 20, 2 | 2021-04-20 |
Triphenylphosphonium-derivative Compounds For Eradicating Cancer Stem Cells
App 20200376008 - LISANTI; Michael P. ; et al. | 2020-12-03 |
Repurposcins: Targeted Inhibitors Of Mitochondrial Biogenesis For Eradicating Cancer Stem Cells
App 20200360411 - LISANTI; Michael P. ; et al. | 2020-11-19 |
Anti-mitochondrial Inhibitors For Oncogenic Ras And Myc
App 20200292551 - LISANTI; Michael P. ; et al. | 2020-09-17 |
Companion Diagnostics For Mitochondrial Inhibitors
App 20200255902 - LISANTI; Michael P. ; et al. | 2020-08-13 |
Mitoflavoscins: Targeting Flavin-containing Enzymes Eliminates Cancer Stem Cells (cscs) By Inhibiting Mitochondrial Respiration
App 20200246344 - Kind Code | 2020-08-06 |
Mitoketoscins: Mitochondrial-based Therapeutics Targeting Ketone Metabolism In Cancer Cells
App 20200207775 - Lisanti; Michael P. ; et al. | 2020-07-02 |
Antimitoscins: Targeted Inhibitors Of Mitochondrial Biogenesis For Eradicating Cancer Stem Cells
App 20200179424 - LISANTI; Michael P. ; et al. | 2020-06-11 |
Mitoriboscins: Mitochondrial-based Therapeutics Targeting Cancer Cells, Bacteria And Pathogenic Yeast
App 20200170967 - Lisanti; Michael P. ; et al. | 2020-06-04 |
Mitoketoscins: Mitochondrial-based Therapeutics Targeting Ketone Metabolism In Cancer Cells
App 20200148688 - LISANTI; Michael P. ; et al. | 2020-05-14 |
Mitoriboscins: Mitochondrial-based Therapeutics Targeting Cancer Cells, Bacteria And Pathogenic Yeast
App 20200060998 - LISANTI; Michael P. ; et al. | 2020-02-27 |
Vitamin C And Doxycycline: A Synthetic Lethal Combination Therapy For Eradicating Cancer Stem Cells (cscs)
App 20200061086 - LISANTI; Michael P. ; et al. | 2020-02-27 |
Targeting Hypoxic Cancer Stem Cells (cscs) With Doxycycline: Implications For Improving Anti-angiogenic Therapy
App 20200046740 - LISANTI; Michael P. ; et al. | 2020-02-13 |
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
Grant 10,512,618 - Lisanti , et al. Dec | 2019-12-24 |
Mitoriboscins: Mitochondrial-based Therapeutics Targeting Cancer Cells, Bacteria, And Pathogenic Yeast
App 20190091181 - LISANTI; Michael P. ; et al. | 2019-03-28 |
| 